| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |